Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2025-12-24 @ 12:43 PM
NCT ID:
NCT07088861
Eligibility Criteria:
Inclusion Criteria:
* Age 18-75 years old and gender
* Long-term residence in a non-high prevalence area for nasopharyngeal cancer
* Histologically confirmed primary nasopharyngeal cancer (without any treatment)
* Completed MRI examination of nasopharynx and neck with image quality meeting the needs of imaging analysis
* All receiving a standard comprehensive treatment plan with radiotherapy as the core
* Adequate bone marrow, liver, and kidney function (meeting laboratory index thresholds)
* ECOG 0-1, KPS ≥ 70 points, and life expectancy \> 3 months
* No previous history of immune disorders
Exclusion Criteria:
* Received radiotherapy, chemotherapy, or surgery to the primary site or lymph nodes
* Severe underlying disease (heart failure, renal failure, etc.), uncontrolled active infection, active autoimmune disease, or history of autoimmune disease requiring immunosuppressive therapy
* Pregnant or breastfeeding females
* Irregular radiotherapy or missing treatment data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07088861
Study Brief:
Protocol Section:
NCT07088861